发明授权
US07645769B2 Inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders relating to apoptosis and/or inflammation
有权
用于治疗与凋亡和/或炎症相关的神经变性疾病的c-Jun N-末端激酶抑制剂
- 专利标题： Inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders relating to apoptosis and/or inflammation
- 专利标题（中）： 用于治疗与凋亡和/或炎症相关的神经变性疾病的c-Jun N-末端激酶抑制剂
-
申请号： US11499334申请日： 2006-08-04
-
公开(公告)号： US07645769B2公开(公告)日： 2010-01-12
- 发明人: Afzal Khan , Darren Peter Medland , Gurpreet Singh Bhatia
- 申请人： Afzal Khan , Darren Peter Medland , Gurpreet Singh Bhatia
- 申请人地址： JP
- 专利权人： Eisai R & D Management Co., Ltd.
- 当前专利权人： Eisai R & D Management Co., Ltd.
- 当前专利权人地址： JP
- 代理机构： Wilmer Cutler Pickering Hale & Dorr LLP.
- 优先权： GB0516156.7 20050805
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/4375
摘要：
The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
公开/授权文献
信息查询
